PTC Therapeutics has received FDA approval for a gene therapy to treat AADC deficiency, a rare genetic disorder that impairs ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

Finally, the number of opportunities in the biosimilars space is very high — there are more than 300 biologics in the market, ...

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

Collaboration to leverage Steritas’ STOX Suite in developing innovative treatments for autoimmune diseases.

A serious adverse event in the New York biotech’s phase 1/2 trial of its Rett syndrome gene therapy puts a question mark over ...

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of ...

The two companies have formed Oblenio Bio to develop a tri-specific T-cell engager The U.S. company Aditum Bio and Chinese company Leads Biolabs today announced that they have founded Oblenio Bio, a ...